Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers
NCT02452996
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
GNbAC1
Sponsor
GeNeuro Innovation SAS